Truth, Inspiration, Hope.

US

US Submarine Collides With Unknown Object in South China Sea
On Oct. 2, the USS Connecticut struck a mysterious object while submerged in the South China Sea. It...
Employees of Merck Serono look from the headquarter's windows on April 24, 2012 in Geneva. Researchers from the University of North Carolina have said Merck’s new COVID-19 pill based on molnupiravir “Will be incorporated in the DNA.”
Merck’s COVID Pill ‘Will be Incorporated in the DNA’: Researcher
Merck’s newly announced pill to treat Coronavirus Disease 2019 (COVID-19) based on the molnupiravir compound...
Republicans and Democrats are at loggerheads when it comes to raising the debt ceiling.
Biden May Counter Filibuster to Raise Debt Ceiling, Republicans Wary of ‘Socialist’ Infrastructure Bill
President Joe Biden has said that Democrats might make an exception to the filibuster rule to pass legislation...
Lt. Col. Stuart Scheller Charged With Six Violations Ahead of Court-Martial
Lt. Col. Stuart Scheller has been granted a conditional release from military jail and is now charged...
Senate Reaches Agreement to Raise National Debt Ceiling
On Oct. 7, The U.S. Senate agreed, as expected, to a provisional increase in the national debt ceiling...
Pfizer Expects FDA Approval to Vaccinate Children Under 12 by Halloween
Pharma giant Pfizer/BioNTech announced on Thursday that the company is seeking FDA approval for its COVID...
People wait in line for COVID-19 vaccines at Kedren Community Health Center on January 25, 2021 in Los Angeles, California. A new study by a Harvard and a Turner Fenton scientist published in the European Journal of Epidemiology has found “no discernible relationship” between vaccine acceptance rate and increasing positive PCR test count in 68 countries and 2947 U.S. counties.
‘No Discernable Relationship’ Between Vaccination Rate and New COVID-19 Cases Across 68 Countries: Study
A recent study examining data across 68 countries, including 2,947 counties located in the United States...
The headquarters of Merck in Darmstadt on November 22, 2019 in Germany. Merck’s antiviral COVID-19 pill, molnupiravir, was developed with $35 million in NIH and NIAID taxpayer funding at Emory University. Now, Merck is selling it back to the government at 35 times the cost of its generic counterpart.
The NIAID and NIH Financed Development of Merck’s COVID Pill, Now They’re Selling to Taxpayers at 3,500%
Merck’s recently announced pill-based antiviral treatment for COVID-19 was researched and developed at...
William Shatner to Travel to Space on Jeff Bezos’ Next Blue Origin Mission
It’s been thirty years since William Shatner’s alter ego, James T. Kirk, last uttered his legendary command...